1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

BACKGROUND: Voriconazole (VCZ) is used as mold active primary antifungal prophylaxis (AFP) after allogenic hematopoietic cell transplant (HCT) but is frequently discontinued due to adverse events (AE), variable pharmacokinetics and drug-drug interactions. Limited data exists on the safety of Isavuco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogler, Yael, Stern, Anat, Su, Yiqi, Lee, Yeon Joo, Seo, Susan K, Giralt, Sergio, Perales, Miguel-Angel, Neofytos, Dionysios, Papanicolaou, Genovefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776786/
http://dx.doi.org/10.1093/ofid/ofaa439.1474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776786/
http://dx.doi.org/10.1093/ofid/ofaa439.1474

Ejemplares similares